Prekės kodas: PREK00763
Turimas kiekis:
The rapid COVID-19 antigen test is a set of immunochromatographic assays for the qualitative detection of SARS-CoV-2 antigens in a smear taken from the human anterior nasal cavity. Suitable for self-monitoring purposes.
The rapid COVID-19 antigen test is a set of immunoassays for the rapid and qualitative detection of SARS-CoV-2 infection in samples. The SARS-CoV-2 antigens in the samples reacted with the anti-SARS-CoV-2 antibody monoclonal gold conjugate, which then reacts with the anti-SARS-CoV-2 antibodies immobilized in the test line region. If SARS-CoV-2 antigens are present in the sample, a visible line appears on the membrane in the area of the test line. The solution further migrates to contact the control reagent, which binds the control conjugate and thus forms another band in the control area.
The rapid COVID-19 antigen test is a membrane immunochromatographic assay that uses highly sensitive monoclonal antibodies to detect the SARS-CoV-2 nucleocapsid protein in a smear taken from the nasopharynx. The test cartridge strip consists of the following parts: sample, reagent, reaction membrane, and absorbent portion. The reagent portion contains colloidal gold conjugated to monoclonal antibodies against the SARS-CoV-2 nucleocapsid protein. The reaction membrane contains secondary antibodies to the SARS-CoV-2 nucleocapsid protein. The tape is built inside the plastic cassette. When the sample is added to the sample well, the dried conjugates in the reagent portion dissolve and migrate with the sample. If the sample contains SARS-CoV-2 antigen, the complex formed between the anti-SARS-2 conjugate and the virus will be captured by specific anti-SARS-2 monoclonal antibodies coated in the test line region (T). The absence of a T line indicates a negative result. A red line is used for the procedural control, which always appears in the control line area (C) as confirmation that the correct amount of sample has been used for the test and a membrane has formed.
